Cargando…

Effectiveness and safety of glimepiride and iDPP4, associated with metformin in second line pharmacotherapy of type 2 diabetes mellitus: systematic review and meta‐analysis

OBJECTIVE: Our review analyses the studies that have specifically compared the association iDPP4/metformin with glimepiride/metformin, both in second line pharmacotherapy of type 2 diabetes mellitus (DM2). METHODS: Systematic literature review with a meta‐analysis of clinical trials comparing glimep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amate, JM., Lopez‐Cuadrado, T., Almendro, N., Bouza, C., Saz‐Parkinson, Z., Rivas‐Ruiz, R., Gonzalez‐Canudas, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Endocrinology and Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024024/ https://www.ncbi.nlm.nih.gov/pubmed/25683794 http://dx.doi.org/10.1111/ijcp.12605

Ejemplares similares

Glimepiride and Metformin Combinations in Diabetes Comorbidities and Complications: Real-World Evidence
por: Sahay, Rakesh Kumar, et al.
Publicado: (2020)

Real-World Observational Study of Glimepiride and Metformin Fixed-Dose Combination Along With Insulin in the Management of Type 2 Diabetes Mellitus: Indian Experience
por: Prasanna Kumar, KM, et al.
Publicado: (2021)

Executive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19()
por: Carrasco-Sánchez, Francisco Javier, et al.
Publicado: (2022)

Epidemiology and recent trends of severe sepsis in Spain: a nationwide population-based analysis (2006-2011)
por: Bouza, Carmen, et al.
Publicado: (2014)

Balloon kyphoplasty in malignant spinal fractures: a systematic review and meta-analysis
por: Bouza, Carmen, et al.
Publicado: (2009)

Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma
por: Bouza, Carmen, et al.
Publicado: (2009)

Anti-diabetic combination therapy with pioglitazone or glimepiride added to metformin on the AGE-RAGE axis: a randomized prospective study
por: Ragazzi, Eugenio, et al.
Publicado: (2023)

Efficacy of Primary Prevention Interventions When Fasting and Postglucose Dysglycemia Coexist: Analysis of the Indian Diabetes Prevention Programmes (IDPP-1 and IDPP-2)
por: Ramachandran, Ambady, et al.
Publicado: (2010)

Metformin-Induced Vitamin B12 Deficiency in Patients With Type-2 Diabetes Mellitus
por: Tiwari, Aakriti, et al.
Publicado: (2023)

Effects of Evogliptin as Add on in Type 2 Diabetes (T2DM) Subjects Inadequately Controlled With Metformin and Glimepiride Combination
por: Guha, Shaibal
Publicado: (2021)

Metformin for Preventing Progression From Prediabetes to Diabetes Mellitus in People Living With Human Immunodeficiency Virus
por: Nimitphong, Hataikarn, et al.
Publicado: (2022)

Prediction and Prevention of Gestational Diabetes Mellitus and Its Sequelae by Administering Metformin in the Early Weeks of Pregnancy
por: Seshiah, V, et al.
Publicado: (2022)

Prevalence of Vitamin B12 Deficiency in Type 2 Diabetes Mellitus Patients on Metformin Therapy
por: TS, Rathis, et al.
Publicado: (2023)

FDA-Approved Pharmacotherapy for Weight Loss Over the Last Decade
por: Idrees, Zarwa, et al.
Publicado: (2022)

Effects of Pharmacotherapy for the Treatment of Obesity in an Urban, Safety-Net Population
por: Kim, Eric K, et al.
Publicado: (2023)

ODP173 Control of Alpelisib-Induced Hyperglycemia With DPP4- Inhibitors as add on to Metformin and Insulin
por: Hee, Nicholas Ken Yoong, et al.
Publicado: (2022)

Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
por: Nyström, Thomas, et al.
Publicado: (2017)

Advances in Anti-obesity Pharmacotherapy: Current Treatments, Emerging Therapies, and Challenges
por: Brandfon, Skyler, et al.
Publicado: (2023)

Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
por: Nyström, Thomas, et al.
Publicado: (2018)

Dapagliflozin Versus Vildagliptin as an Adjuvant to Metformin in Patients With Type 2 Diabetes Mellitus: A Randomized, Open-label Study
por: Gautam, Kumar, et al.
Publicado: (2023)

A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled by glimepiride and metformin
por: Lee, Seung-Hwan, et al.
Publicado: (2017)

Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
por: Jeon, Hyun Jeong, et al.
Publicado: (2011)

A Case of Euglycemic Diabetic Ketoacidosis (DKA), Influenza, and a Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
por: Jeong, Su Hyun, et al.
Publicado: (2023)

Metformin Use and Metformin-associated Lactic Acidosis in Intensive Care Unit Patients with Diabetes
por: Rajasurya, Venkat, et al.
Publicado: (2019)

Metformin-Induced Acute Hepatitis
por: Mian, Arooj, et al.
Publicado: (2023)

An Evaluation of the Second Trimester Thyroid Function Test in Gestational Diabetes Mellitus: A Case-Control Study
por: Srivastava, Himsweta, et al.
Publicado: (2023)

Metformin, but not glimepiride, improves carotid artery diameter and blood flow in patients with type 2 diabetes mellitus
por: Machado, Helena Atroch, et al.
Publicado: (2012)

The Anti-Breast Cancer Effect and Mechanism of Glimepiride-Metformin Adduct
por: Long, Liangyuan, et al.
Publicado: (2020)

A pharmacoeconomic analysis to compare cost-effectiveness of metformin plus teneligliptin with metformin plus glimepiride in patients of type-2 diabetes mellitus
por: Tandon, Tanya, et al.
Publicado: (2019)

Clinical Use of DPP-4 Inhibitors
por: Gallwitz, Baptist
Publicado: (2019)

Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial
por: Sidelmann Christensen, Alexander, et al.
Publicado: (2018)

Metformin-associated Lactic Acidosis: An Unexpected Scenario
por: Asif, Samia, et al.
Publicado: (2019)

The Future of Metformin in the Prevention of Diabetes-Related Osteoporosis
por: Aung, Myat, et al.
Publicado: (2020)

A Case of Metformin-Associated Lactic Acidosis
por: Mahmood, Rabia, et al.
Publicado: (2023)

The importance of weight management in type 2 diabetes mellitus
por: Wilding, J P H
Publicado: (2014)

Real-World Observational Study on Vildagliptin With Insulin (VIL-INS) or Vildagliptin and Metformin With Insulin (VIL-MET-INS) Therapy in Indian Patients With Type 2 Diabetes Mellitus
por: Panneerselvam, P, et al.
Publicado: (2023)

Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trials
por: Zhu, Hongmei, et al.
Publicado: (2013)

The DPP-4 Inhibitor Linagliptin Counteracts Stroke in the Normal and Diabetic Mouse Brain: A Comparison With Glimepiride
por: Darsalia, Vladimer, et al.
Publicado: (2013)

Reactive Hypoglycemia From Metformin Immediate-Release Monotherapy Resolved by a Switch to Metformin Extended-Release: Conceptualizing Their Concentration-Time Curves
por: Akram, Ayesha
Publicado: (2021)

Metformin-Induced Lactic Acidosis: A Case Study
por: Chowdhury, Waliul, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0aplg6bcb7eajo5hg6jbtuf0vp